FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

116087001: Cilostazol (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
177258015 Cilostazol en Synonym Active Entire term case insensitive SNOMED CT core module
674808016 Cilostazol (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cilostazol Is a Medicinal product acting as antiplatelet agent (product) false Inferred relationship Existential restriction modifier
Cilostazol Is a Antiplatelet agent false Inferred relationship Existential restriction modifier
Cilostazol Is a Substance with phosphodiesterase inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Cilostazol Has disposition Phosphodiesterase inhibitor false Inferred relationship Existential restriction modifier
Cilostazol Is a Chemical categorized functionally false Inferred relationship Existential restriction modifier
Cilostazol Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Cilostazol Is a Amide true Inferred relationship Existential restriction modifier
Cilostazol Is a Tetrazole true Inferred relationship Existential restriction modifier
Cilostazol Has disposition Platelet aggregation inhibitor true Inferred relationship Existential restriction modifier
Cilostazol Is a Substance with platelet aggregation inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier
Cilostazol Is a Vasodilator true Inferred relationship Existential restriction modifier
Cilostazol Is a Substance with phosphodiesterase 3 inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Cilostazol Has disposition Phosphodiesterase 3 inhibitor true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cilostazol 50mg tablets (Consilient Health Ltd) 56 tablet 4 x 14 tablets Has precise active ingredient True Cilostazol Inferred relationship Existential restriction modifier 1
Cilostazol 50mg tablets (Consilient Health Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Cilostazol Inferred relationship Existential restriction modifier
Cilostazol 100mg tablets (Consilient Health Ltd) 56 tablet 4 x 14 tablets Has basis of strength substance True Cilostazol Inferred relationship Existential restriction modifier 1
Cilostazol 100mg tablets (Consilient Health Ltd) 56 tablet 4 x 14 tablets Has precise active ingredient True Cilostazol Inferred relationship Existential restriction modifier 1
Cilostazol 100mg tablets (Consilient Health Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Cilostazol Inferred relationship Existential restriction modifier

Start Page 2 of 2

This concept is not in any reference sets

Back to Start